Literature DB >> 2848058

Nucleolar organiser regions in normal, cirrhotic, and carcinomatous livers.

J Crocker1, J McGovern.   

Abstract

A series of 54 liver biopsy specimens was studied by means of the argyrophil (AgNOR) technique for nucleolar organiser region (NOR)-associated proteins. These included normal livers and livers affected by chronic active hepatitis, cirrhosis, hepatocellular carcinoma and adenoma. Four of the cases of cirrhosis showed liver cell dysplasia. The mean numbers of NOR sites in normal, cirrhotic, and carcinomatous livers were significantly different: adenoma had similar mean counts to those in chronic active hepatitis (CAH). There was no overlap between the ranges of NOR counts in normal, cirrhotic, and malignant liver specimens. Where cirrhosis and hepatocellular carcinoma were present in the same specimen, the AgNOR counts were higher in the carcinomatous than cirrhotic areas. To investigate the prospective value of the method a further seven biopsy specimens were studied; in these it had not been possible to decide on a diagnosis between normality and cirrhosis or cirrhosis and hepatocellular carcinoma. In all seven specimens a repeat biopsy or necropsy gave results as predicted by AgNOR staining. It is therefore proposed that quantitation of staining for NOR-associated proteins is a diagnostically useful method in liver disease.

Entities:  

Mesh:

Year:  1988        PMID: 2848058      PMCID: PMC1141685          DOI: 10.1136/jcp.41.10.1044

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  16 in total

1.  Hormone-modulated rRNA gene activity is visualized by selective staining of the NOs.

Authors:  A de Capoa; A Baldini; P Marlekaj; C Natoli; M Rocchi; N Archidiacono; S Cianfarani; G L Spadoni; B Boscherini
Journal:  Cell Biol Int Rep       Date:  1985-09

2.  Nucleolar organiser regions in fibrous proliferations of childhood and infantile fibrosarcoma.

Authors:  M J Egan; F Raafat; J Crocker; K Smith
Journal:  J Clin Pathol       Date:  1988-01       Impact factor: 3.411

3.  Differentiation of malignant from normal and reactive mesothelial cells by the argyrophil technique for nucleolar organiser region associated proteins.

Authors:  J G Ayres; J G Crocker; N Q Skilbeck
Journal:  Thorax       Date:  1988-05       Impact factor: 9.139

4.  Nucleolar organizer regions in small cell tumours of childhood.

Authors:  M J Egan; F Raafat; J Crocker; K Smith
Journal:  J Pathol       Date:  1987-11       Impact factor: 7.996

5.  Nucleolar silver-staining patterns related to cell cycle phase and cell generation of PHA-stimulated human lymphocytes.

Authors:  D H Field; P H Fitzgerald; F Y Sin
Journal:  Cytobios       Date:  1984

6.  Lesions of the renal papilla induced by paracetamol.

Authors:  M A Henry; J D Tange
Journal:  J Pathol       Date:  1987-01       Impact factor: 7.996

7.  Nucleolar organiser region associated proteins in cutaneous melanotic lesions: a quantitative study.

Authors:  J Crocker; N Skilbeck
Journal:  J Clin Pathol       Date:  1987-08       Impact factor: 3.411

8.  Rearrangement and possible amplification of the ribosomal RNA gene sites in the human chronic myelogenous leukemia cell line K562.

Authors:  P E Crossen; J M Godwin
Journal:  Cancer Genet Cytogenet       Date:  1985-09

9.  Silver staining of nucleolar granules in tumor cells.

Authors:  H Busch; Y Daskal; F Gyorkey; K Smetana
Journal:  Cancer Res       Date:  1979-03       Impact factor: 12.701

10.  Nucleolar organiser regions in small cell carcinoma of the bronchus.

Authors:  J Crocker; J Ayres; J McGovern
Journal:  Thorax       Date:  1987-12       Impact factor: 9.139

View more
  22 in total

1.  Argyrophilic nucleolar organiser region (AgNOR) staining in normal bone marrow cells.

Authors:  E P Nikicicz; D H Norback
Journal:  J Clin Pathol       Date:  1990-09       Impact factor: 3.411

2.  Silver-stained nucleolar organizer regions in the normal, hyperplastic and neoplastic endometrium.

Authors:  K Niwa; Y Yokoyama; T Tanaka; H Mori; H Mori; T Tamaya
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

Review 3.  Molecular biology and respiratory disease. 3. Evaluation of nucleolar organiser regions in pulmonary pathology.

Authors:  M J Egan; J Crocker
Journal:  Thorax       Date:  1990-03       Impact factor: 9.139

4.  A quantitative study of silver-stained NORs in different segments of the normal human colorectal crypt.

Authors:  M Morais; P Dockery; F H White
Journal:  J Anat       Date:  1996-06       Impact factor: 2.610

5.  Hepatocyte proliferation rate is a powerful parameter for predicting hepatocellular carcinoma development in liver cirrhosis.

Authors:  M Borzio; D Trerè; F Borzio; A R Ferrari; S Bruno; M Roncalli; G Colloredo; G Leandro; F Oliveri; M Derenzini
Journal:  Mol Pathol       Date:  1998-04

6.  Validation of silver-stained nucleolar organizer regions for evaluation of invasive character of urinary bladder carcinoma in rats and mice.

Authors:  H Iwata; T Otoshi; N Takada; T Murai; S Tamano; T Watanabe; Y Katsura; S Fukushima
Journal:  Urol Res       Date:  1995

7.  Argyrophilic nucleolar organizer region counts in exocrine pancreatic tumors.

Authors:  T Ohta; T Nagakawa; Y Tsukioka; K Mori; M Kayahara; M Kanno; K Ueno; I Miyazaki; T Terada; Y Nakanuma
Journal:  Int J Pancreatol       Date:  1992-12

8.  [Study on the relationship between most cells and tumor growth speed during hepatocarcinogenesis in the rats].

Authors:  Y B Ruan; Z B Wu
Journal:  J Tongji Med Univ       Date:  1993

9.  Correlation between PCNA and AgNOR scores in non-Hodgkin's lymphomas using sequential staining technique.

Authors:  F G Smith; P G Murray; J Crocker
Journal:  J Clin Pathol       Date:  1993-01       Impact factor: 3.411

10.  Regional differences in bromodeoxyuridine uptake, expression of Ki-67 protein, and nucleolar organizer region counts in glioblastoma multiforme.

Authors:  K Onda; R L Davis; C B Wilson; T Hoshino
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.